title: Preventing deaths due to the hypertensive disorders of pregnancy.
abstract: In this chapter, taking a life cycle and both civil society and medically oriented approach, we will discuss the contribution of the hypertensive disorders of pregnancy (HDPs) to maternal, perinatal and newborn mortality and morbidity. Here we review various interventions and approaches to preventing deaths due to HDPs and discuss effectiveness, resource needs and long-term sustainability of the different approaches. Societal approaches, addressing sustainable development goals (SDGs) 2.2 (malnutrition), 3.7 (access to sexual and reproductive care), 3.8 (universal health coverage) and 3c (health workforce strengthening), are required to achieve SDGs 3.1 (maternal survival), 3.2 (perinatal survival) and 3.4 (reduced impact of non-communicable diseases (NCDs)). Medical solutions require greater clarity around the classification of the HDPs, increased frequency of effective antenatal visits, mandatory responses to the HDPs when encountered, prompt provision of life-saving interventions and sustained surveillance for NCD risk for women with a history of the HDPs.
authors.affiliation: Institute of Cardiovascular and Cell Sciences, St George's University of London, UK; Department of Obstetrics and Gynaecology, St George's University Hospitals NHS Foundation Trust, London, UK. Electronic address: pvd@sgul.ac.uk.
authors.forename: Peter
authors.initials: P
authors.lastname: von Dadelszen
authors.affiliation: Institute of Cardiovascular and Cell Sciences, St George's University of London, UK; Department of Obstetrics and Gynaecology, St George's University Hospitals NHS Foundation Trust, London, UK.
authors.forename: Laura A
authors.initials: LA
authors.lastname: Magee
mesh_terms: D001241:Aspirin / Q000627:therapeutic use*; D001721:Birth Intervals; D002118:Calcium / Q000627:therapeutic use*; D015148:Cardiotocography; D019587:Dietary Supplements; D004461:Eclampsia / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy*; D005260:Female; D005523:Food Supply; D006268:Health Facilities; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D046110:Hypertension, Pregnancy-Induced / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy; D007231:Infant, Newborn; D008403:Mass Screening; D063130:Maternal Death / Q000209:etiology / Q000517:prevention & control*; D009765:Obesity; D010358:Patient Participation; D066087:Perinatal Death / Q000209:etiology / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011225:Pre-Eclampsia / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy*; D016742:Preconception Care; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000175:diagnosis / Q000628:therapy; D011295:Prenatal Care; D011507:Proteinuria / Q000175:diagnosis; D043762:Reproductive Behavior; D050497:Stillbirth
chemical_list: D010975:Platelet Aggregation Inhibitors; D001241:Aspirin; D002118:Calcium
keywords: maternal mortality; medical interventions; pregnancy hypertension; societal interventions